Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 7/27/20 → 9/21/22 |
Funding
- 9 Meters Biopharma Incorporated: $38,199.00
A Phase 3, Randomized, Double-Blind, Placebo Controlled Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Treatment of Celiac Disease
- Flomenhoft, Deborah (PI)